DOI QR코드

DOI QR Code

Down-regulation of Long Non-coding RNA TUG1 Inhibits Osteosarcoma Cell Proliferation and Promotes Apoptosis

  • Zhang, Qiang (Department of Orthopedics, Chinese PLA General Hospital) ;
  • Geng, Pei-Liang (Cancer Center, Chinese PLA General Hospital & Chinese PLA Medical School) ;
  • Yin, Pei (Department of Nephrology, The First Affiliated Hospital, Chinese PLA General Hospital) ;
  • Wang, Xiao-Lin (Department of Neurology, Chinese PLA General Hospital) ;
  • Jia, Jin-Peng (Department of Orthopedics, Chinese PLA General Hospital) ;
  • Yao, Jie (Department of Oncology, PLA No. 161 Center Hospital)
  • 발행 : 2013.04.30

초록

Objective: To investigate the expression level of TUG1 and one of its transcript variants (n377360) in osteosarcoma cells and assess the role of TUG1 in proliferation and apoptosis in the U2OS cell line. Methods: TUG1 and n377360 expression levels in patients with osteosarcomas and the U2OS human osteosarcoma cell line were evaluated using real-time quantitative PCR. U2OS cells were transected with TUG1 and n377360 siRNA or non-targeting siRNA. MTS was performed to assess the cell proliferation and flow cytometry was applied to analyze apoptosis. Results: We found significantly higher TUG1 and n377360 expression levels in osteosarcoma tissues compared with matched non-tumorous tissues. In line with this, suppression of TUG1 and n377360 expression by siRNA significantly impaired the cell proliferation potential of osteosarcoma cells. Furthermore, inhibition of TUG1 expression significantly promoted osteosarcoma cell apoptosis. Conclusions: The overexpression of TUG1 and n377360 in osteosarcoma specimens and the functional role of TUG1 and n377360 regarding cell proliferation and apoptosis in an osteosarcoma cell line provided evidence that the use of TUG1 or n377360 may be a viable but an as yet unexplored therapeutic strategy in tumors that over express these factors.

과제정보

연구 과제 주관 기관 : National Natural Science

참고문헌

  1. Akiyama T, Dass CR, Choong PF (2008). Novel therapeutic strategy for osteosarcoma targeting osteoclast differentiation, bone-resorbing activity, and apoptosis pathway. Mol Cancer Ther, 7, 3461-9. https://doi.org/10.1158/1535-7163.MCT-08-0530
  2. Gupta RA, Shah N, Wang KC, et al (2010). Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature, 464, 1071-6. https://doi.org/10.1038/nature08975
  3. Huarte M, Guttman M, Feldser D, et al (2010). A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell, 142, 409-19. https://doi.org/10.1016/j.cell.2010.06.040
  4. Ji P, Diederichs S, Wang W, et al., (2003). MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene, 22, 8031-41. https://doi.org/10.1038/sj.onc.1206928
  5. Khalil AM, Guttman M, Huarte M, et al (2009). Many human large intergenic noncoding RNAs associate with chromatinmodifying complexes and affect gene expression. Proc Natl Acad Sci U S A, 106, 11667-72. https://doi.org/10.1073/pnas.0904715106
  6. Kino T, Hurt DE, Ichijo T, et al (2010). Noncoding RNA gas5 is a growth arrest-and starvation-associated repressor of the glucocorticoid receptor. Sci Signal, 3, ra8. https://doi.org/10.1126/scisignal.2000568
  7. Matouk IJ, DeGroot N, Mezan S, et al (2007). The H19 noncoding RNA is essential for human tumor growth. PLoS One, 2, e845. https://doi.org/10.1371/journal.pone.0000845
  8. Qureshi A, Ahmad Z, Azam M, et al (2010). Epidemiological data for common bone sarcomas. Asian Pac J Cancer Prev, 11, 393-5.
  9. Pandey RR, Mondal T, Mohammad F, et al (2008). Kcnq1ot1 antisense noncoding RNA mediates lineage-specific transcriptional silencing through chromatin-level regulation. Mol Cell, 32, 232-46. https://doi.org/10.1016/j.molcel.2008.08.022
  10. Pasic I, Shlien A, Durbin AD, et al (2010). Recurrent focal copy-number changes and loss of heterozygosity implicate two noncoding RNAs and one tumor suppressor gene at chromosome 3q13.31 in osteosarcoma. Cancer Res, 70, 160-71. https://doi.org/10.1158/0008-5472.CAN-09-1902
  11. Pasmant E, Laurendeau I, Heron D, et al (2007). Characterization of a germ-line deletion, including the entire INK4/ARF locus, in a melanoma-neural system tumor family: identification of ANRIL, an antisense noncoding RNA whose expression coclusters with ARF. Cancer Res, 67, 3963-9. https://doi.org/10.1158/0008-5472.CAN-06-2004
  12. Poliseno L, Salmena L, Zhang J, et al (2010). A codingindependent function of gene and pseudogene mRNAs regulates tumour biology. Nature, 465, 1033-8. https://doi.org/10.1038/nature09144
  13. Ponting CP, Oliver PL, Reik W (2009). Evolution and functions of long noncoding RNAs. Cell, 136, 629-41. https://doi.org/10.1016/j.cell.2009.02.006
  14. Spizzo R, Almeida MI, Colombatti A, et al (2012). Long noncoding RNAs and cancer: a new frontier of translational research? Oncogene, 31, 4577-87. https://doi.org/10.1038/onc.2011.621
  15. Yang L, Lin C, Liu W, et al (2011) ncRNA-and Pc2 methylationdependent gene relocation between nuclear structures mediates gene activation programs. Cell, 147, 773-88. https://doi.org/10.1016/j.cell.2011.08.054
  16. Young TL, Matsuda T, Cepko CL (2005) The noncoding RNA taurine upregulated gene 1 is required for differentiation of the murine retina. Curr Biol, 15, 501-12. https://doi.org/10.1016/j.cub.2005.02.027
  17. Zhang X, Gejman R, Mahta A, et al (2010) Maternally expressed gene 3, an imprinted noncoding RNA gene, is associated with meningioma pathogenesis and progression. Cancer Res, 70, 2350-8. https://doi.org/10.1158/0008-5472.CAN-09-3885

피인용 문헌

  1. Extraskeletal Ewing Sarcomas in Late Adolescence and Adults: A Study of 37 Patients vol.14, pp.5, 2013, https://doi.org/10.7314/APJCP.2013.14.5.2967
  2. Optimization of Reference Genes for Normalization of the Quantitative Polymerase Chain Reaction in Tissue Samples of Gastric Cancer vol.15, pp.14, 2014, https://doi.org/10.7314/APJCP.2014.15.14.5815
  3. Molecular function and regulation of long non-coding RNAs: paradigms with potential roles in cancer vol.35, pp.11, 2014, https://doi.org/10.1007/s13277-014-2636-z
  4. Long non-coding RNA TUG1 is up-regulated in hepatocellular carcinoma and promotes cell growth and apoptosis by epigenetically silencing of KLF2 vol.14, pp.1, 2015, https://doi.org/10.1186/s12943-015-0431-0
  5. Role of lncRNAs in health and disease--size and shape matter vol.14, pp.2, 2015, https://doi.org/10.1093/bfgp/elu034
  6. Upregulation of the long noncoding RNA TUG1 promotes proliferation and migration of esophageal squamous cell carcinoma vol.36, pp.3, 2015, https://doi.org/10.1007/s13277-014-2763-6
  7. Overexpression of Long Non-Coding RNA HOTAIR Promotes Tumor Growth and Metastasis in Human Osteosarcoma vol.38, pp.5, 2015, https://doi.org/10.14348/molcells.2015.2327
  8. Long non-coding RNA-DANCR in human circulating monocytes: a potential biomarker associated with postmenopausal osteoporosis vol.79, pp.5, 2015, https://doi.org/10.1080/09168451.2014.998617
  9. High Expression of HULC Is Associated with Poor Prognosis in Osteosarcoma Patients vol.11, pp.6, 2016, https://doi.org/10.1371/journal.pone.0156774
  10. The long non-coding RNA TUG1 indicates a poor prognosis for colorectal cancer and promotes metastasis by affecting epithelial-mesenchymal transition vol.14, pp.1, 2016, https://doi.org/10.1186/s12967-016-0786-z
  11. ANRIL is associated with the survival rate of patients with colorectal cancer, and affects cell migration and invasion in vitro vol.14, pp.2, 2016, https://doi.org/10.3892/mmr.2016.5409
  12. Long noncoding RNA TUG1 is downregulated in non-small cell lung cancer and can regulate CELF1 on binding to PRC2 vol.16, pp.1, 2016, https://doi.org/10.1186/s12885-016-2569-6
  13. LncRNA Taurine-Upregulated Gene 1 Promotes Cell Proliferation by Inhibiting MicroRNA-9 in MCF-7 Cells vol.19, pp.4, 2016, https://doi.org/10.4048/jbc.2016.19.4.349
  14. LncRNA TUG1 acts as a tumor suppressor in human glioma by promoting cell apoptosis vol.241, pp.6, 2016, https://doi.org/10.1177/1535370215622708
  15. Overexpression of the long noncoding RNA TUG1 protects against cold-induced injury of mouse livers by inhibiting apoptosis and inflammation vol.283, pp.7, 2016, https://doi.org/10.1111/febs.13660
  16. Overexpression of long non-coding RNA TUG1 predicts poor prognosis and promotes cancer cell proliferation and migration in high-grade muscle-invasive bladder cancer vol.37, pp.10, 2016, https://doi.org/10.1007/s13277-016-5177-9
  17. Long non-coding RNA TUG1 contributes to tumorigenesis of human osteosarcoma by sponging miR-9-5p and regulating POU2F1 expression vol.37, pp.11, 2016, https://doi.org/10.1007/s13277-016-5391-5
  18. Long non-coding RNAs: emerging players in osteosarcoma vol.37, pp.3, 2016, https://doi.org/10.1007/s13277-015-4749-4
  19. P50-associated COX-2 extragenic RNA (PACER) overexpression promotes proliferation and metastasis of osteosarcoma cells by activating COX-2 gene vol.37, pp.3, 2016, https://doi.org/10.1007/s13277-015-3838-8
  20. Upregulation of MALAT-1 and its association with survival rate and the effect on cell cycle and migration in patients with esophageal squamous cell carcinoma vol.37, pp.4, 2016, https://doi.org/10.1007/s13277-015-4223-3
  21. Upregulation of long non-coding RNA TUG1 correlates with poor prognosis and disease status in osteosarcoma vol.37, pp.4, 2016, https://doi.org/10.1007/s13277-015-4301-6
  22. Increased expression of long noncoding RNA TUG1 predicts a poor prognosis of gastric cancer and regulates cell proliferation by epigenetically silencing of p57 vol.7, pp.2, 2016, https://doi.org/10.1038/cddis.2015.356
  23. Targeting the Notch-regulated non-coding RNA TUG1 for glioma treatment vol.7, pp.2041-1723, 2016, https://doi.org/10.1038/ncomms13616
  24. Long noncoding RNAs in the progression, metastasis, and prognosis of osteosarcoma vol.7, pp.9, 2016, https://doi.org/10.1038/cddis.2016.272
  25. Long noncoding RNAs in the p53 network vol.8, pp.3, 2016, https://doi.org/10.1002/wrna.1410
  26. Long noncoding and circular RNAs in lung cancer: advances and perspectives vol.8, pp.9, 2016, https://doi.org/10.2217/epi-2016-0036
  27. Long non-coding RNAs as an epigenetic regulator in human cancers vol.108, pp.10, 2017, https://doi.org/10.1111/cas.13342
  28. Long non-coding RNA TUG1 promotes migration and invasion by acting as a ceRNA of miR-335-5p in osteosarcoma cells vol.108, pp.5, 2017, https://doi.org/10.1111/cas.13201
  29. : potential biomarkers for gastric cancer diagnosis and clinically monitoring cancer progression vol.11, pp.12, 2017, https://doi.org/10.2217/bmm-2017-0090
  30. LncRNA-ANCR regulates the cell growth of osteosarcoma by interacting with EZH2 and affecting the expression of p21 and p27 vol.12, pp.1, 2017, https://doi.org/10.1186/s13018-017-0599-7
  31. Down-regulation of LncRNA TUG1 enhances radiosensitivity in bladder cancer via suppressing HMGB1 expression vol.12, pp.1, 2017, https://doi.org/10.1186/s13014-017-0802-3
  32. Exploring Consensus RNA Substructural Patterns Using Subgraph Mining vol.14, pp.5, 2017, https://doi.org/10.1109/TCBB.2016.2645202
  33. Roles of Long Noncoding RNAs in Recurrence and Metastasis of Radiotherapy-Resistant Cancer Stem Cells vol.18, pp.9, 2017, https://doi.org/10.3390/ijms18091903
  34. Long non-coding RNA taurine upregulated 1 enhances tumor-induced angiogenesis through inhibiting microRNA-299 in human glioblastoma vol.36, pp.3, 2017, https://doi.org/10.1038/onc.2016.212
  35. Prognostic and clinicopathological role of long non-coding RNA taurine upregulated 1 in various human malignancies: A systemic review and meta-analysis vol.39, pp.7, 2017, https://doi.org/10.1177/1010428317714361
  36. LncRNA TUG1 influences papillary thyroid cancer cell proliferation, migration and EMT formation through targeting miR-145 vol.49, pp.7, 2017, https://doi.org/10.1093/abbs/gmx047
  37. Upregulation of long noncoding RNA TUG1 promotes cervical cancer cell proliferation and migration vol.6, pp.2, 2017, https://doi.org/10.1002/cam4.994
  38. Long Noncoding RNAs as a Key Player in Hepatocellular Carcinoma vol.9, pp.1179-299X, 2017, https://doi.org/10.1177/1179299X17737301
  39. Current Status of Long Non-Coding RNAs in Human Cancer with Specific Focus on Colorectal Cancer vol.15, pp.8, 2014, https://doi.org/10.3390/ijms150813993
  40. P53-regulated long non-coding RNA TUG1 affects cell proliferation in human non-small cell lung cancer, partly through epigenetically regulating HOXB7 expression vol.5, pp.5, 2014, https://doi.org/10.1038/cddis.2014.201
  41. Transcription factor Oct4 promotes osteosarcoma by regulating lncRNA AK055347 vol.13, pp.1, 2016, https://doi.org/10.3892/ol.2016.5400
  42. Antidifferentiation Noncoding RNA Regulates the Proliferation of Osteosarcoma Cells vol.31, pp.2, 2016, https://doi.org/10.1089/cbr.2015.1888
  43. Potentials of Long Noncoding RNAs (LncRNAs) in Sarcoma: From Biomarkers to Therapeutic Targets vol.18, pp.4, 2017, https://doi.org/10.3390/ijms18040731
  44. Overexpression of long noncoding RNA PEG10 promotes proliferation, invasion and metastasis of hypopharyngeal squamous cell carcinoma vol.14, pp.3, 2017, https://doi.org/10.3892/ol.2017.6498
  45. Taurine-upregulated gene 1: A vital long non-coding RNA associated with cancer in humans vol.16, pp.5, 2017, https://doi.org/10.3892/mmr.2017.7472
  46. TUG1 promotes osteosarcoma tumorigenesis by upregulating EZH2 expression via miR-144-3p vol.51, pp.4, 2017, https://doi.org/10.3892/ijo.2017.4110
  47. Long non-coding RNA XIST regulates PDCD4 expression by interacting with miR-21-5p and inhibits osteosarcoma cell growth and metastasis vol.51, pp.5, 2017, https://doi.org/10.3892/ijo.2017.4127
  48. Up-Regulation of Long Noncoding RNA CCAL Predicts Poor Patient Prognosis and Promotes Tumor Metastasis in Osteosarcoma vol.32, pp.1, 2017, https://doi.org/10.5301/jbm.5000240
  49. Long Non-Coding RNA TUG1 Promotes Proliferation and Inhibits Apoptosis of Osteosarcoma Cells by Sponging miR-132-3p and Upregulating SOX4 Expression vol.59, pp.2, 2018, https://doi.org/10.3349/ymj.2018.59.2.226
  50. Long non-coding RNA: its evolutionary relics and biological implications in mammals: a review vol.60, pp.1, 2018, https://doi.org/10.1186/s40781-018-0183-7
  51. Long noncoding RNA TUG1 promotes cell proliferation and migration of renal cell carcinoma via regulation of YAP vol.119, pp.12, 2018, https://doi.org/10.1002/jcb.27284
  52. Multidimensional communication of microRNAs and long non-coding RNAs in lung cancer pp.1432-1335, 2018, https://doi.org/10.1007/s00432-018-2767-5
  53. Long noncoding RNA expression in the cervix mid-pregnancy is associated with the length of gestation at delivery vol.13, pp.7, 2018, https://doi.org/10.1080/15592294.2018.1503490
  54. TUG1 promotes prostate cancer progression by acting as a ceRNA of miR-26a vol.38, pp.5, 2018, https://doi.org/10.1042/BSR20180677
  55. Long non-coding RNA taurine-upregulated gene 1 predicts unfavorable prognosis, promotes cells proliferation, and inhibits cells apoptosis in epithelial ovarian cancer vol.97, pp.19, 2018, https://doi.org/10.1097/MD.0000000000010575
  56. Taurine-upregulated gene 1 contributes to cancers through sponging microRNA vol.51, pp.2, 2018, https://doi.org/10.1093/abbs/gmy156
  57. Deregulation of long noncoding RNA (TUG1) contributes to excessive podocytes apoptosis by activating endoplasmic reticulum stress in the development of diabetic nephropathy pp.00219541, 2019, https://doi.org/10.1002/jcp.28153
  58. LncRNA HOXA-AS2 Facilitates Tumorigenesis and Progression of Papillary Thyroid Cancer by Modulating the miR-15a-5p/HOXA3 Axis pp.1557-7422, 2019, https://doi.org/10.1089/hum.2018.109